Fernanda Galvanini

• End-to-end portfolio management, accountable for an annual revenue of USD 28M.

• Accountable for driving Bavencio’s performance in 2023, achieving a 49% growth compared to the previous year.

• Led Merck & Pfizer Alliance (co-promotion of Bavencio) for co-creation of Brazil’s brand and communication strategy.

• Led the digital marketing journey, focusing on social media strategy and website creation for the product and disease, leveraging analytical skills to inform decision-making.

• Accountable for KOL’s relationship and development across the country, being an ambassador for Latin America and Global.

• Led the private sector inclusion plan for Tepmetko (tepotinib) in Brazil, overseeing the dossier preparation, digital communication strategy, and stakeholder engagement efforts.

• Accountable for Spinraza (nusinersen), a product indicated for SMA, overseeing a brand that generated $143M in sales in 2021.

• Implemented brand strategy, communication, social media, awareness campaigns, medical segmentation and brand positioning.

• Achieved a 37% increase in patients undergoing treatment compared to the previous year.

• Led the inclusion of Spinraza in the public sector for SMA, developing a tailored plan for key stakeholders.

• Extensive interaction with regional and global teams, including monthly competitor reporting and implementation of global projects, materials and social media digital campaigns.

• Redesign Spinraza’s patient support program, ensuring comprehensive end-to-end services for patients.

• Strategy, communication and execution of the marketing and sales launch plan for Piqray (alpelisib), the first specific product for PI3KCA mutation in metastatic Breast Cancer, with Brazil being the second launching country in the world.

• Built and led patient-centric initiatives for Pink October, effectively communicating with both medical and general communities about breast cancer awareness.

• Engaged with patient associations and participation in projects across social media, journals, clinics, and hospitals.

• Design and implementation of the Breast Cancer Patient Support Program, including the PIK3CA mutation testing platform in partnership with the country's main laboratories in Brazil.

• Initiated and managed global and regional projects at the national level, facilitating seamless collaboration with both teams.

• Responsible for the Renal and Sarcoma franchise, including Votrient and Afinitor RCC, growing 37% vs 2017.

• Led multichannel and digital projects to raise awareness of renal cancer, including campaigns for World Kidney Cancer Day.

• Planned and executed major congresses and brand events, ensuring right messages and content for healthcare sustainability.

• Strong collaboration with access teams and medical society to develop and execute a comprehensive communication plan for Votrient’s submission for Public Access approval.

• Successfully engaged all relevant stakeholders during the public consultation process, resulting in the inclusion of the product into the public sector.

• Marketing Analyst for Entresto (heart failure), Diovan & Exforge Family (hypertension), mature products (Cataflam, Voltarem, Rosulib, Plagrel), and the non-promoted in CV mature line.

• Led the communication plan for pre-marketing initiatives related to Heart Failure, targeting both external and internal audiences.

• Led the development of the patient support program for Heart Failure and orchestrated the pre-marketing promotional campaign, post-registration initiatives, digital communication campaigns, medical events, and continuing education programs.

• Contributed to the development of promotional campaigns for the entire Oncology Portfolio at Novartis, including Renal Cancer (Votrient), Breast Cancer (Afinitor), Melanoma (Tanfilar & Meknist), and Neuroendocrine Tumors (Sandostation Lar).

• Analyzed and managed Business Unit (BU) investments, supported congresses and events, facilitated patient programs, collaborated with the field force, and oversaw interns and marketing assistants.

• Overseeing advertising and promotional activities, targeting physicians (Neurologists/Psychiatrists) and pharmacies across the main eight regions (neighborhoods) of São Paulo. Creating and fostering strong relationship with key stakeholders in the sector.

• Portfolio Products: Ritalin LA, Trileptal, Tegretol CR, Anafranil Sr, Leponex, Neotiapim, and Pamelor (ADHD, Epilepsy, Bipolar Disorder, OCD, Schizophrenia, Depression).

• Support to the line’s main launch - Gilenya (Multiple Sclerosis) and, in addition to mature products such as Stalevo, Comtan, Leponex, Olcadil, and Neotiapim (Parkinson, Schizophrenia, Anxiety, and bipolar disorder).

• Developed marketing materials, provided field force support for all events, managed internal approvals, co-created digital and communication strategies, and implemented patient support programs.

• Auditing area, working as a trainee, and Junior Analyst.

• Core Responsibilities: Conducted in-depth analysis of balance sheets, validated financial statements, engaged with clients, and participated in physical inventories for major clients such as Itaú Unibanco Holding S.A., Makro, Sabesp, and Ipsos.